CA Patent

CA3010183C — Systems and methods for long term transdermal administration

Assigned to Corium LLC · Expires 2025-12-09 · 0y expired

What this patent protects

The systems and devices described herein are designed for prolonged or long term transdermal administration of an active agent. The compositions may be used in devices, patches or systems suitable for transdermal delivery of the active agent. The devices and systems have a compos…

USPTO Abstract

The systems and devices described herein are designed for prolonged or long term transdermal administration of an active agent. The compositions may be used in devices, patches or systems suitable for transdermal delivery of the active agent. The devices and systems have a composite layer comprising a plurality of segments that are at least partially separated, which makes them especially useful for long term delivery of the active agent from the device. For the long term delivery, the system must remain adhered or substantially adhered to the administration site as delivery of the active agent from the transdermal device requires contact between the agent containing layer and the administration site (directly or indirectly). Most transdermal patches cannot or do not remain sufficiently adhered to the skin for an extended period of more than a couple of days.

Drugs covered by this patent

Patent Metadata

Patent number
CA3010183C
Jurisdiction
CA
Classification
Expires
2025-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Corium LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.